Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Joe Wesley who wrote (1828)	3/19/1998 4:30:00 PM
From: marc ultra	Read Replies (1) \| Respond to of 4676

Amateur, Did you hear something about 2302 progress and plans I didn't know or missed? If so would appreciate the info Thanks, Marc

To: Joe Wesley who wrote (1828)	3/19/1998 11:44:00 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 4676

Hi Amateur: >>Sounds like we will have a lot to hear at the open house.<< Better said a lot questions. I will need two week for preparation. >>One question from abstract is Bob Glazer working for Isis now?<< Do not know. Didn't checked. Sound to me like collaboration. Regards the new BI deal, I do not see needs for it. Unless Isis want to give BI development of topical preparation for lower royalty. Their collaboration on small molecules cells adhesion inhibitors (three different cells/receptors involved) may be revised. At least they will have (I hope) new deal with Novartis on sec-gen/new target/2503. Miljenko

To: Joe Wesley who wrote (1828)	3/20/1998 8:48:00 AM
From: emil	Read Replies (1) \| Respond to of 4676

Looks like traders don't like something in the annual report. Bid/ask dropping at the open...